Indian Heart Journal (Nov 2022)

Development and validation of a mobile application based on a machine learning model to aid in predicting dosage of vitamin K antagonists among Indian patients post mechanical heart valve replacement

  • M. Amruthlal,
  • S. Devika,
  • Vignesh Krishnan,
  • P.A. Ameer Suhail,
  • Aravind K. Menon,
  • Alan Thomas,
  • Manu Thomas,
  • G. Sanjay,
  • L.R. Lakshmi Kanth,
  • P. Jeemon,
  • Jimmy Jose,
  • S. Harikrishnan

Journal volume & issue
Vol. 74, no. 6
pp. 469 – 473

Abstract

Read online

Patients who undergo heart valve replacements with mechanical valves need to take Vitamin K Antagonists (VKA) drugs (Warfarin, Nicoumalone) which has got a very narrow therapeutic range and needs very close monitoring using PT-INR. Accessibility to physicians to titrate drugs doses is a major problem in low-middle income countries (LMIC) like India. Our work was aimed at predicting the maintenance dosage of these drugs, using the de-identified medical data collected from patients attending an INR Clinic in South India. We used artificial intelligence (AI) - machine learning to develop the algorithm. A Support Vector Machine (SVM) regression model was built to predict the maintenance dosage of warfarin, who have stable INR values between 2.0 and 4.0. We developed a simple user friendly android mobile application for patients to use the algorithm to predict the doses. The algorithm generated drug doses in 1100 patients were compared to cardiologist prescribed doses and found to have an excellent correlation.

Keywords